Stents and Stocks: Private Equity's Involvement in Interventional Cardiology
This session explores the growing role of private equity (PE) in interventional cardiology and its impact on clinical practice. Presenters will examine why PE is entering the space, how acquisitions affect quality of care, and the legal and compliance challenges that follow. A firsthand account will offer insight into the realities of PE ownership. Attendees will gain a deeper understanding of the strategic, operational, and ethical considerations involved.